Pharmacokinetics, Absorption, and Excretion of Radiolabeled Revexepride: A Phase I Clinical Trial Using a Microtracer and Accelerator Mass Spectrometry-Based Approach

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s107843
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Determining the Pharmacokinetics and Long-Term Biodistribution of SiO2Nanoparticles in Vivo Using Accelerator Mass Spectrometry

Nano Letters
Materials ScienceCondensed Matter PhysicsMechanical EngineeringNanoscienceBioengineeringNanotechnologyChemistry
2012English

Accelerator Mass Spectrometry

Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms
High Energy PhysicsInstrumentationNuclear
2010English

Accelerator Mass Spectrometry

English

Accelerator Mass Spectrometry

AIP Conference Proceedings
AstronomyPhysics
2001English

Disposition and Metabolic Profiling of [14C]Cerlapirdine Using Accelerator Mass Spectrometry

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2014English

Measurements of 10Be and 26Al by Accelerator Mass Spectrometry.

Journal of the Mass Spectrometry Society of Japan
1991English

Accelerator Mass Spectrometry in Nuclear Physics

Journal of Physics G: Nuclear and Particle Physics
High Energy PhysicsNuclear
1991English

A Phase I Study to Assess the Mass Balance, Excretion, and Pharmacokinetics of [14c]-Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors

Investigational New Drugs
OncologyPharmacology
2017English

Metabolic Fate of Midodrine. (I). Absorption and Excretion.

Drug Metabolism and Pharmacokinetics
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy